Efficacy of Licensed Monoclonal Antibodies and Antiviral Agents against the SARS-CoV-2 Omicron Sublineages BA.1 and BA.2.
Viruses
; 14(7)2022 06 23.
Article
in En
| MEDLINE
| ID: mdl-35891355
Key words
Full text:
1
Database:
MEDLINE
Main subject:
SARS-CoV-2
/
COVID-19 Drug Treatment
Limits:
Humans
Language:
En
Year:
2022
Type:
Article